Bezafibrate

Back to search

Molecule Structure

Scientific Name

Bezafibrate

Description of the Drug

Bezafibrate is a lipid-lowering fibrate used in the management of primary and secondary hyperlipidaemia, when there is a lack of clinical improvement following lifestyle modifications or correction of the underlying disorder.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01393

Brand Name(s)

Bezagen xl, Bezalip, Bezalip-mono, Fibrazate xl, Liparol xl, Zimbacol xl

Company Owner(s)

Not Available

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Peroxisome proliferator-activated receptor PROTEIN FAMILY AGONIST CHEMBL3559683

Unichem Links

Atlas bezafibrate
SureChEMBL SCHEMBL16299
PharmGKB PA162364313
Human Metabolome Database HMDB0015465
DrugBank DB01393
PubChem: Thomson Pharma 14926008
PubChem 39042
Mcule MCULE-9775992840
LINCS LSM-3015
Nikkaji J16.626J
PDBe PEM
BindingDB 28701
EPA CompTox Dashboard DTXSID3029869
DrugCentral 362
Brenda 105590
ChemicalBook CB1188501
Guide to Pharmacology 2668
rxnorm BEZAFIBRATE
PubChem: Drugs of the Future 12015374
ChEBI 47612
ZINC ZINC000003956919